A randomized single-blind placebo-controlled study of a Visnadine Emulgel formulation on healthy postmenopausal women
- Minerva Ginecol. 2019 Oct;71(5):353-358. doi: 10.23736/S0026-4784.19.04398-3.
- 1. Derming Institute of Clinical Research and Bioengineering, Milan, Italy.
- 2. Istituto di Evoluzione Sessuale (IES), Milan, Italy - [email protected].
- 3. Istituto di Evoluzione Sessuale (IES), Milan, Italy.
- 4. AlmaMed, Milan, Italy.
Background: There is a growing interest on women' sexual function improvement provided by topical vulvar application of Visnadine, a natural extractive substance with putative vasodilatory properties. Aims of this study were to evaluate: 1) the vasokinetic activity of a Visnadine Emulgel on mucosal genitalia of 15 healthy postmenopausal women clinically and by instrumental non-invasive analysis; 2) the treatment efficacy by volunteers' judgment regarding to subjective comfort, pleasant warmth, lubrication grade, pinching and burning vulvar sensations.
Methods: Fifteen informed healthy female volunteers with menopause were enrolled in the study, with a single blind controlled study versus placebo corresponding to one single application of the emulgel product (active or placebo) on external genitalia.
Results: Visnadine Emulgel single application determined a significant increase of vulvar hyperemia, evaluated both clinically and instrumentally, accompanied by a significant increase of local turgor versus placebo. The volunteers reported a pleasant comfort sensation.
Conclusions: The topical use of Visnadine on female external genitalia may increase regional vascularization affecting turgidity and sensorial threshold of the area of application.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: OthersResearch Areas: Cardiovascular Disease